Erratum: Long Noncoding RNA UCA1 Targets miR-122 to Promote Proliferation, Migration, and Invasion of Glioma Cells

Originally published in Volume 26, No. 1, pages 103-110, 2018 (doi:https://doi.org/10.3727/096504017X14934860122864) Glioma is the most common and lethal malignant intracranial tumor. Long noncoding RNAs (lncRNAs) have been identified as pivotal regulators in the tumorigenesis of glioma. However, th...

Full description

Saved in:
Bibliographic Details
Published inOncology research Vol. 28; no. 6; pp. 683 - 684
Main Authors Sun, Yang, Jin, Jun-Gong, Mi, Wei-Yang, Hao-Wu, Zhang, Shi-Rong, Meng, Qiang, Zhang, Shi-Tao
Format Journal Article
LanguageEnglish
Published Elmsford, NY Cognizant Communication Corporation 16.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Originally published in Volume 26, No. 1, pages 103-110, 2018 (doi:https://doi.org/10.3727/096504017X14934860122864) Glioma is the most common and lethal malignant intracranial tumor. Long noncoding RNAs (lncRNAs) have been identified as pivotal regulators in the tumorigenesis of glioma. However, the role of lncRNA urothelial carcinoma-associated 1 (UCA1) in glioma genesis is still unknown. The purpose of this study was to investigate the underlying function of UCA1 on glioma genesis. The results demonstrated that UCA1 was upregulated in glioma tissue and indicated a poor prognosis. UCA1 knockdown induced by si-UCA1 significantly suppressed the proliferative, migrative, and invasive activities of glioma cell lines (U87 and U251). Bioinformatics analysis and luciferase reporter assay verified the complementary binding within UCA1 and miR-122 at the 3′-UTR. Functional experiments revealed that UCA1 acted as an miR-122 "sponge" to modulate glioma cell proliferation, migration, and invasion via downregulation of miR-122. Overall, the present study demonstrated that lncRNA UCA1 acts as an endogenous sponge of miR-122 to promote glioma cell proliferation, migration, and invasion, which provides a novel insight and therapeutic target in the tumorigenesis of glioma.
Bibliography:(RC) Practice of Medicine
0965-0407(20200316)28:6L.683;1-
ISSN:0965-0407
DOI:10.3727/096504021X16137463165433